Scientific Program

Organizers: W. Ray Kim , Zeki Karasu, Ramazan İdilman
Scientific Secretariat: Levent Doğanay, Gupse Adalı, Aslı Örmeci, Fatih Güzelbulut, İlker Şen

TIME	HALL 1
08:30-08:40	Introduction W. Ray Kim, Zeki Karasu
	Session 1 - Abstract Presentations Moderators: Gökhan Kabaçam, Arif M. Coşar
08:40-10:10	6 Oral Presentations
08:40-08:50	Prognostic and therapeutic insights into LTBP1 in Hepatocellular Carcinoma: pathway enrichment, immune profiling, and drug repurposing Esra Nalbat
08:50-08:55	Discussion
08:55-09:05	Long term efficacy, effectiveness and side effects of third line therapies in autoimmune hepatitis Ilkay Ergenc
09:05-09:10	Discussion
09:10-09:20	Risk Factors for Primary Sclerosing Cholangitis Recurrence Following Liver Transplantation: A Retrospective Analysis from Türkiye Gupse Adali
09:20-09:25	Discussion
09:25-09:35	Unveiling molecular biomarkers of MASLD fibrosis: A transcriptomic and pathway enrichment analysis Deniz Cansen Kahraman
09:35-09:40	Discussion
09:40-09:50	Killer Cell Immunoglobulin-Like Receptors (KIRs) Gene Variants in Primary Biliary Cholangitis and Autoimmune Hepatitis Pathogenesis Mete Ucdal
09:50-09:55	Discussion
09:55-10:05	Whole exome sequencing analysis for the diagnosis in adults with liver disease of unknown etiology Kenan Moral
10:05-10:10	Discussion
	Session 2 - Steatotic Liver Disease 1: Obesity and MASLD Moderators: Yusuf Yılmaz, Ümit Akyüz
10:10-10:30	TLM Debrief: MASLD Mary Rinella
10:30-10:50	Incretins in Obesity and MASLD Sumeet K. Asrani
10:50-11:10	Multidisciplinary Management of Obesity and MASLD Cem Şimşek, Hasan Altun
11:10-11:55	Case-Based Panel Discussion (2 Case Presenters) and Q&A Gupse Adalı, Çağlayan Keklikkıran
11:55-13:00	Lunch Break
13:00-13:30	Session 3 - Debate #1 HCC Screening in MASH Patients With F3 Fibrosis: I Do, I Do Not Judges: Mary Rinella, Sumeet K. Asrani Şencan Acar & Hasan Eruzun vs Kenan Moral & Şefikcan Biricik
	Session 4 - Steatotic Liver Disease 2: ALD Moderators: Halis Şimşek, Murat Kıyıcı
13:30-13:50	TLM Debrief: ALD Sumeet K. Asrani
13:50-14:10	Hepatologist's Guide to metALD Mary Rinella
14:10-14:30	Practical Approach to Alcohol-Associated Hepatitis Coşkun Demirtaş
14:30-15:15	Case-Based Panel Discussion (2 Case Presenters) and Q&A Volkan Yılmaz, İlker Şen
15:15-15:40	Coffee Break
	Session 5 - Brief Updates Moderators: Fulya Günşar, Yasemin Balaban
15:40-16:00	TLM Debrief: Autoimmune/Cholestatic Liver Disease Mary Rinella
16:00-16:20	TLM Debrief: Pediatric Liver Disease Çiğdem Arıkan
16:20-17:25	Case-Based Panel Discussion (2 Case Presenters) and Q&A Cumali Efe, Aslı Örmeci

TIME	HALL 1
08:00-08:05	Opening
	Session 6 - Liver Transplantation Moderators: Zeki Karasu, Sezai Yılmaz
08:05-08:25	TLM Update: Liver Transplantation Jackie O'Leary
08:25-08:45	Update: Liver Transplantation for ALD Sumeet K. Asrani
08:45-09:05	Deceased Cardiac Donor LT: State of the Art Paul Y. Kwo
09:05-09:50	Case-Based Panel Discussion (2 Case Presenters) and Q&A Hale Gokcan, Elvan Işık
09:50-10:15	Coffee Break
	Session 7 - HCC Moderators: Nuri Erçin, Levent Doğanay
10:15-10:35	TLM Debrief: HCC Jackie O'Leary
10:35-10:55	Hepato-Oncology in the Era of Systemic Therapy W. Ray Kim
10:55-11:15	Update: Cholangiocarcinoma Tevfik Tolga Şahin
11:15-12:00	Case-Based Panel Discussion (2 Case Presenters) and Q&A Fatih Güzelbulut, Dilara Turan
12:00-13:00	Lunch Break
13:00-13:30	Session 8 - Debate #2 Portal Vein Thrombosis in Cirrhosis: I Start Anticoagulant Therapy, I Do Not Judges: Paul Y. Kwo, Jackie O'Leary Salih Tokmak & Sercan Kiremitçi vs İlkay Ergenç & Zulal İstemihan
	Session 9 - Cirrhosis and Portal Hypertension Moderators: Meral Akdoğan, Fatih Beşışık
13:30-13:50	TLM Debrief: Portal Hypertension Jackie O'Leary
13:50-14:10	TIPS and Other Radiological Interventions Bora Peynircioğlu
14:10-14:30	Update: Acute on Chronic Liver Failure Paul Y. Kwo
14:30-15:15	Case-Based Panel Discussion (2 Case Presenters) and Q&A Suna Yapalı, Nilay Danış
15:15-15:40	Coffee Break
	Session 10 - Viral Hepatitis Moderators: Ramazan İdilman, Murat Akyıldız
15:40-16:00	TLM Debrief: Viral Hepatitis W. Ray Kim
16:00-16:20	Update on Delta Hepatitis Bülent Değertekin
16:20-16:40	Update on Hepatitis B Cure Paul Y. Kwo
16:40-17:25	Case-Based Panel Discussion (2 Case Presenters) and Q&A Onur Keskin, Zeynep M. Ellik
17:25-17:30	Closing

IMPORTANT DATES

14 February

Congress Start Date

15 February

Congress End Date

26 January

Abstract Last
Submission Date